Combination therapy with cell-binding domain, angiogenesis inhibitor and Ca<sup>2+</sup> channel blocker in mice metastatic model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy with cell-binding domain, angiogenesis inhibitor and Ca²⁺ channel blocker in mice metastatic model

Published:2008 Issue:2 Volume:16 Page:31-35
ISSN:1344-6835
Container-title:Annals of Cancer Research and Therapy
language:en
Short-container-title:Ann. Cancer Res. Therap.

Author:

Saito Noboru¹²,Mitsuhashi Maki¹,Sakasai Yukiyo³,Kameoka Shingo¹

Affiliation:

1. Department of Surgery II, Tokyo Women's Medical University School of Medicine

2. Department of General Medicine, Tokyo Women's Medical University School of Medicine

3. Central Clinical Laboratories, Tokyo Women's Medical University School of Medicine

Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://www.jstage.jst.go.jp/article/acrt/16/2/16_2_31/_pdf

Reference42 articles.

1. 1) Sàndor, E. (2006) Molecular targeted therapy: A strategy of disillusions or optimism? J. Labo. Clin. Med. 147:108-113.

2. 2) Saijo, N., Nishio, K., Tamura, T. (2003) Translational and clinical studies of target-based cancer therapy. Int. J. Clin. Oncol. 8:187-192.

3. 3) Maehara, Y., Egashira, A., Kakeji, Y. (2006) Current topics and the clinical effects of target-based antineoplastic agents. Int. J. Clin. Oncol. 11:164-166.

4. 4) Zelent, A., Petrie, K., Chen, Z., Lotan, R., Lübbert, M., Tallman, M.S., Ohno, R., Degos, L., Waxman, S. (2005) Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy. Cancer Research. 65:1117-1123.

5. 5) Johann, S.B., Anthony, W.T., Eric, K.R. (2003) The future of cytotoxic therapy: selective cytotoxicity based on biology is the key. Breast Cancer Res. 5:154-159.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3